Log in or Sign up for Free to view tailored content for your specialty!
Esophagus News
Household detergent exposure may be linked to eosinophilic esophagitis
Sodium dodecyl sulfate, a common household detergent, decreased the integrity of the esophageal barrier, stimulated IL-33 production and promoted epithelial hyperplasia and tissue eosinophilia, according to a study published in Allergy.
Use of acid suppressant medications in infancy raises childhood risk for wheeze, asthma
Infants exposed to acid suppressant medications did not experience an increased risk for allergen sensitization in early childhood, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.
Log in or Sign up for Free to view tailored content for your specialty!
Patients with eosinophilic esophagitis symptoms may benefit from gastric emptying studies
Gastric emptying studies may benefit patients with persistent symptoms of eosinophilic esophagitis who do not respond to treatment, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.
Q&A: FDA approval of dupilumab for eosinophilic esophagitis a ‘victory for rare diseases’
The FDA has approved the use of dupilumab for treating eosinophilic esophagitis in adults and children aged 12 years and older, making it the first drug in the U.S. specifically indicated for this condition.
FDA approves miniature capsule formulation of omeprazole magnesium for heartburn
The FDA has given final approval to Perrigo Co.’s miniature 20 mg delayed-release omeprazole magnesium capsules for over-the-counter treatment of frequent heartburn., according to a company press release.
Study dispels misconceptions of anti-reflux surgery with proof of symptom resolution
SAN DIEGO — Patients who underwent laparoscopic anti-reflux surgery for gastroesophageal reflux disease experienced long-term improvement in symptoms commonly misperceived to persist, according to study results.
FDA approves first treatment for eosinophilic esophagitis in the US
The FDA has granted approval for dupilumab for the treatment of eosinophilic esophagitis for adult and pediatric patients aged 12 years and older, according to a press release.
‘New tools’ offer hope for diverse gastrointestinal symptoms in systemic sclerosis
DESTIN, Fla. — Stepwise interventions, starting with diet and moving on to pharmacotherapies in more severe patients, is essential to managing gastrointestinal complications in scleroderma, a speaker said at the Congress of Clinical Rheumatology East.
Increased rates of esophageal cancer, BE in middle-aged adults prompt concern
Between 2012 and 2019, esophageal cancer rates nearly doubled and prevalence of Barrett’s esophagus increased by 50% among adults aged 45 to 64 years, according to researchers.
Esophageal Cancer Awareness Month: Updated guidance, treatment options, FDA news and more
Esophageal cancer is one of the deadliest forms of cancer with an estimated 19,260 diagnoses and 15,530 deaths in the United States last year, the American Association for Cancer Research reported.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read